Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland
· Delayed Price · Currency is CHF
9.72
-0.18 (-1.82%)
Mar 3, 2025, 5:31 PM CET
Newron Pharmaceuticals Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Mar '25 Mar 3, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 198 | 88 | 28 | 29 | 38 | 113 | |
| Market Cap Growth | 39.38% | 219.35% | -4.32% | -24.65% | -66.14% | 13.19% | |
| Enterprise Value | 233 | 118 | 44 | 34 | 23 | 91 | |
| Last Close Price | 9.90 | 4.95 | 1.55 | 1.62 | 2.15 | 6.35 | |
| Forward PE | 11.36 | - | 7.84 | - | - | - | |
| PS Ratio | 26.86 | 10.48 | 4.59 | 4.84 | 6.74 | 14.81 | |
| PB Ratio | -5.13 | -3.17 | -2.00 | 8.97 | 2.06 | 2.83 | |
| P/TBV Ratio | - | - | - | 8.98 | 2.06 | 2.83 | |
| EV/Sales Ratio | 34.70 | 13.95 | 7.26 | 5.77 | 4.13 | 11.93 | |
| Debt / Equity Ratio | -1.58 | -1.62 | -3.25 | 13.87 | 1.53 | 0.46 | |
| Asset Turnover | 0.25 | 0.29 | 0.14 | 0.11 | 0.09 | 0.12 | |
| Quick Ratio | 3.28 | 0.61 | 5.50 | 10.58 | 5.50 | 7.89 | |
| Current Ratio | 3.73 | 0.68 | 5.65 | 10.79 | 5.50 | 8.13 | |
| Return on Equity (ROE) | - | - | - | -146.43% | -77.71% | -44.10% | |
| Return on Assets (ROA) | -33.24% | -23.05% | -18.96% | -15.19% | -20.26% | -21.72% | |
| Return on Capital (ROIC) | -42.51% | -28.99% | -21.37% | -17.20% | -23.21% | -24.01% | |
| Earnings Yield | -9.18% | -17.09% | -62.50% | -53.44% | -59.23% | -19.38% | |
| FCF Yield | -6.52% | -10.70% | -39.69% | -41.12% | -44.07% | -21.13% | |
| Buyback Yield / Dilution | -2.01% | - | - | - | - | -0.01% | |
| Total Shareholder Return | -2.01% | - | - | - | - | -0.01% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.